U.S.-Iran Talks May Take Days as Oil Prices React to Strait of Hormuz Tensions 
Dow Hits Record High as Healthcare and Consumer Stocks Lead Wall Street Rally 
U.S. Launches New Strikes on Iran as Trump Signals Peace Deal Uncertainty 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
Gold Prices Slip as Stronger Dollar and Iran Peace Talk Uncertainty Weigh on Market 
NIO CEO Says China’s Auto Industry Has Passed Its Golden Era Amid Weak Car Sales 
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination 
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026 
Uruguay Central Bank Holds Interest Rate at 5.75% Amid Inflation and Oil Price Concerns 
ECB’s Philip Lane Warns Middle East Conflict Could Keep Inflation Elevated 
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market 
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules 
RBNZ Holds Interest Rates Steady but Signals More Hikes Ahead in 2026 
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026 
UK Grocery Inflation Slows to 3.1% as Supermarket Price Pressures Ease in May 2026 
S&P 500 Hits Record High as Tech Rally Slows Amid Iran Peace Uncertainty 
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence 
Canon went to court to challenge the EU's sanction related to its acquisition of Toshiba Medical Systems Corporation in 2016 but was defeated. With the decision, the European Union's General Court upheld the €28 million €28 million fine that was previously imposed on the company.
According to Reuters, Canon, a Japanese optical, imaging, and industrial products manufacturer, is now facing a hefty fine, and this was revealed on Wednesday, May 18. It was the second-top court in Europe that sustained the sanction that was originally handed down in 2019.
The European Commission stated in its 2019 decision that Canon violated the rules by the "warehousing" two-step transaction structure where an interim buyer has been assigned to buy the medical unit of Toshiba before it could actually obtain regulatory clearance from the EU's competition agency.
It was reported that under the EU merger regulations, companies that close a deal first without obtaining the EU regulatory approval could be fined by up to 10% of the deal price. The fine is also applicable if companies provide misleading information during the regulatory review.
This unusual method of acquisition allowed Toshiba to book proceeds just in time for the financial year-end ending in March. Originally, this would have been impossible because the company was cash-strapped due to its accounting scandal.
The EU competition slapped Canon with a fine for the said "warehousing," and this week, the Luxembourg-based General Court backed the decision. The judge said, "The European Commission was therefore right to observe that the Court's case-law distinguishes between the concepts of 'concentration' and 'implementation of a concentration.'"
Meanwhile, as previously reported by ITN News, Toshiba Medical Systems' name was changed to Canon Medical Systems Corp. after the acquisition was completed following the deal agreement in 2016.
Canon Inc. and Canon Medical Systems Corp. announced the new name of the newly-acquired company in January 2018. Canon Group was declared the winner in the bidding for the acquisition of CMS with its reported bid of $6.21 billion.
